Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Acumen Pharmaceuticals Inc. Common Stock
ABOS | US
2.57
USD-0.10
-3.75%
ABOS | US
Loading StockChartView...
About Acumen Pharmaceuticals Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
2.57
Open
2.66
High
2.67
Low
2.54
Acumen Pharmaceuticals Inc. a clinical-stage biopharmaceutical company discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193 a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Charlottesville Virginia.
View LessABOS | US
Risk
76.6
Sharpe
1.69
Luna's Score
52/100
Recommendation
Hold
Luna says (ABOS | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
59.4%1 month
76.6%3 months
95.7%6 months
87.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.66
Debt to equity
0.12
Debt to assets
0.10
Ent. to EBITDA
-0.60
Ent. to rev.
89.67
PEG
-
Other Fundamentals
EBITDA
-76.61M
MarketCap
154.41M
MarketCap(USD)
154.41M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-31.43
Short ratio
8.91
Short perc.
3.49
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.54
Range1M
0.82
Range3M
1.72
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.04
Price X volume
1.27M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.60 | 0.53 | Cheaper |
| Ent. to Revenue | 89.67 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.66 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 95.70 | 72.80 | Riskier |
| Debt to Equity | 0.12 | -1.23 | Expensive |
| Debt to Assets | 0.10 | 0.25 | Cheaper |
| Market Cap | 154.41M | 3.66B | Emerging |
